Zenas BioPharma
IPO
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2022
- Business Model
- B2B
- Website
- zenasbio.com
- Total Funding
- $318.0M
- Last Round
- $200.0M Series CMay 2024
About
Zenas BioPharma is a clinical-stage global biopharmaceutical company focused on developing and commercializing transformative immunology-based therapies for autoimmune diseases with significant unmet patient needs. The company's proven leadership team advances a pipeline targeting conditions where current treatments remain inadequate. Zenas operates with a global development model, combining scientific rigor with commercial strategy.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account